Equimax oral gel for horses
Equimax oral gel for horses
Authorised
- Ivermectin
- Praziquantel
Product identification
Medicine name:
Equimax oral gel for horses
Active substance:
- Ivermectin
- Praziquantel
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ivermectin18.70/milligram(s)1.00gram(s)
-
Praziquantel140.30/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral gel
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal35day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 1 syringe or Blister of one syringe.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 2 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 12 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 40 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 48 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 1 syringe or Blister of one syringe.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 2 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 12 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 40 syringes.
- An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 48 syringes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
- Sofarimex-Industria Quimica E Farmaceutica S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V242532
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0501/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 26/04/2026